EP2904086A1 - Tablette mit einem verdichteten stoff - Google Patents
Tablette mit einem verdichteten stoffInfo
- Publication number
- EP2904086A1 EP2904086A1 EP13785505.2A EP13785505A EP2904086A1 EP 2904086 A1 EP2904086 A1 EP 2904086A1 EP 13785505 A EP13785505 A EP 13785505A EP 2904086 A1 EP2904086 A1 EP 2904086A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- textile
- tablet
- solid phase
- agents
- compacted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004744 fabric Substances 0.000 title abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 101
- 239000007790 solid phase Substances 0.000 claims abstract description 81
- 239000000843 powder Substances 0.000 claims abstract description 62
- 239000012736 aqueous medium Substances 0.000 claims abstract description 50
- 239000013543 active substance Substances 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 5
- 239000004753 textile Substances 0.000 claims description 186
- 150000001875 compounds Chemical class 0.000 claims description 33
- 239000003795 chemical substances by application Substances 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 14
- 239000004902 Softening Agent Substances 0.000 claims description 10
- 239000004094 surface-active agent Substances 0.000 claims description 10
- -1 linen Substances 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 239000000645 desinfectant Substances 0.000 claims description 7
- 239000002304 perfume Substances 0.000 claims description 7
- 229920000742 Cotton Polymers 0.000 claims description 5
- 239000000835 fiber Substances 0.000 claims description 5
- 230000001877 deodorizing effect Effects 0.000 claims description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 2
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 2
- 239000004677 Nylon Substances 0.000 claims description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 2
- 239000003899 bactericide agent Substances 0.000 claims description 2
- 239000011425 bamboo Substances 0.000 claims description 2
- 239000000417 fungicide Substances 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 230000003068 static effect Effects 0.000 claims description 2
- 241001330002 Bambuseae Species 0.000 claims 1
- 230000003712 anti-aging effect Effects 0.000 claims 1
- 239000003826 tablet Substances 0.000 description 148
- 239000010410 layer Substances 0.000 description 39
- 239000000047 product Substances 0.000 description 24
- 239000012265 solid product Substances 0.000 description 23
- 238000005406 washing Methods 0.000 description 21
- 239000007788 liquid Substances 0.000 description 15
- 239000012071 phase Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000003599 detergent Substances 0.000 description 12
- 238000005453 pelletization Methods 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- 238000005056 compaction Methods 0.000 description 9
- 238000007906 compression Methods 0.000 description 9
- 230000006835 compression Effects 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 8
- 239000000975 dye Substances 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 239000007844 bleaching agent Substances 0.000 description 5
- 230000009172 bursting Effects 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- FRPJTGXMTIIFIT-UHFFFAOYSA-N tetraacetylethylenediamine Chemical compound CC(=O)C(N)(C(C)=O)C(N)(C(C)=O)C(C)=O FRPJTGXMTIIFIT-UHFFFAOYSA-N 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 3
- 108010065511 Amylases Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 235000019418 amylase Nutrition 0.000 description 3
- 239000002216 antistatic agent Substances 0.000 description 3
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000003352 sequestering agent Substances 0.000 description 3
- 229940045872 sodium percarbonate Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000701 coagulant Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000008394 flocculating agent Substances 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- 238000010412 laundry washing Methods 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008239 natural water Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 235000021436 nutraceutical agent Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
- XIUCEANTZSXBQQ-UHFFFAOYSA-N (3-chloro-2-hydroxypropyl)-trimethylazanium Chemical compound C[N+](C)(C)CC(O)CCl XIUCEANTZSXBQQ-UHFFFAOYSA-N 0.000 description 1
- YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 description 1
- UNWRHVZXVVTASG-UHFFFAOYSA-N 1,3-dichloro-1,3,5-triazinane-2,4,6-trione;sodium Chemical compound [Na].ClN1C(=O)NC(=O)N(Cl)C1=O UNWRHVZXVVTASG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- AMZOGKVWDDFSHF-UHFFFAOYSA-N 2-(dihydroxyamino)ethanol Chemical class OCCN(O)O AMZOGKVWDDFSHF-UHFFFAOYSA-N 0.000 description 1
- XSVSPKKXQGNHMD-UHFFFAOYSA-N 5-bromo-3-methyl-1,2-thiazole Chemical group CC=1C=C(Br)SN=1 XSVSPKKXQGNHMD-UHFFFAOYSA-N 0.000 description 1
- 229910000497 Amalgam Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010004966 Bite Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000012425 OXONE® Substances 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 239000002202 Polyethylene glycol Chemical class 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 102100024304 Protachykinin-1 Human genes 0.000 description 1
- 241000947836 Pseudomonadaceae Species 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 235000007264 Triticum durum Nutrition 0.000 description 1
- 241000209143 Triticum turgidum subsp. durum Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000129 anionic group Chemical class 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 150000001638 boron Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical class 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 150000001804 chlorine Chemical class 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 1
- 229960003988 indigo carmine Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- XEUZNYLPUWEEQE-UHFFFAOYSA-N n-(chloromethyl)benzenesulfonamide Chemical compound ClCNS(=O)(=O)C1=CC=CC=C1 XEUZNYLPUWEEQE-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- HJKYXKSLRZKNSI-UHFFFAOYSA-I pentapotassium;hydrogen sulfate;oxido sulfate;sulfuric acid Chemical compound [K+].[K+].[K+].[K+].[K+].OS([O-])(=O)=O.[O-]S([O-])(=O)=O.OS(=O)(=O)O[O-].OS(=O)(=O)O[O-] HJKYXKSLRZKNSI-UHFFFAOYSA-I 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Chemical class 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229950009390 symclosene Drugs 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 description 1
- MSLRPWGRFCKNIZ-UHFFFAOYSA-J tetrasodium;hydrogen peroxide;dicarbonate Chemical compound [Na+].[Na+].[Na+].[Na+].OO.OO.OO.[O-]C([O-])=O.[O-]C([O-])=O MSLRPWGRFCKNIZ-UHFFFAOYSA-J 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/04—Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0047—Detergents in the form of bars or tablets
- C11D17/0065—Solid detergents containing builders
- C11D17/0073—Tablets
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/52—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment combined with mechanical treatment
- D06M13/525—Embossing; Calendering; Pressing
Definitions
- Tablet comprising a compacted textile
- the present invention relates to a tablet intended to disintegrate at least partially in aqueous medium in order to release one or more active agents, said tablet comprising at least one textile in compacted form.
- Solid products for example in the form of tablets, capable of disintegrating in a liquid, are known, for example in the field of detergency, water treatment, fertilizers, etc. Indeed, the presentation of a product in solid form, or compact, has advantages: the product is easy to handle, store, dose. Thus, it will often be preferred to prepare a solid composition for storing one or more active agents that are to be released in an aqueous medium, for example water, to provide an active solution, for example suitable for cleaning or disinfecting, or also suitable for fertilize plantations or treat unsafe water. Solid products are generally less volume-intensive than liquid products and can therefore be stored more easily.
- a solid product intended to disintegrate in an aqueous medium is generally prepared from a starting mixture consisting of the various ingredients forming the composition of the product, the mixture then being pelletized, for example using a pelletizer, to obtain a product in solid form.
- the various ingredients are generally provided in the starting mixture in the form of powders or grains, sometimes liquids. Pelletizing, by applying a high pressure on the constituents of the mixture, agglomerates these different constituents together and a cohesive solid product is obtained.
- a solid product intended to disintegrate in an aqueous medium must therefore have good cohesion to prevent it from being crumbled, as well as good hardness, so that it can be kept in its integrity until it is used.
- such a solid product must have a hardness high enough not to arrive chipped or broken at the user.
- the solid products or tablets retain their cohesion, stability and good hardness during their storage time, these products must be able to release the active agent (s) they contain at the same time. the moment of their use, that is to say when they are put in contact with an aqueous medium, for example in a washing bath of a washing machine, or in the enclosure of a lava -dishes, or in a pool whose water must be treated, or in a volume of natural water that we seek to purify for example to make it drinkable.
- an aqueous medium for example in a washing bath of a washing machine, or in the enclosure of a lava -dishes, or in a pool whose water must be treated, or in a volume of natural water that we seek to purify for example to make it drinkable.
- disintegration is meant in the sense of the present application, a coarse separation of grains and / or powders, the actual dissolution step may occur simultaneously or later.
- Disintegration kinetics may vary depending on the desired action (s) for the product. For example, rapid disintegration may be required in the case of a product that is used for washing or smelling. Alternatively, one may want to vary the kinetics of disintegration if one wishes several sequential actions of the product, or an action for a fixed period, for example in the treatment of water in general.
- disintegration aid agents for example in the form of powders, may be incorporated in the starting mixture.
- Disintegration aid agents include so-called bursting agents. The bursting agents act by swelling, plastic deformation, wicking effect, when they come into contact with the aqueous medium in which it is desired to dissolve the product or the tablet.
- disintegration aid agents apart from their ability to assist in the disintegration of the product or the tablet, generally have little or no functional interest in the desired application for the product: they generally do not have detergent, biocidal, or other properties. These agents may also be releases which may be harmful to the environment and may induce filter clogging problems for some applications when they are insoluble in nature.
- the solid or tablet products must also preferably fulfill a number of physicochemical and mechanical criteria: in particular, these products must have good chemical stability throughout the storage phase, ie that is to say, be structured in such a way that no chemical reaction of decomposition, transformation, or otherwise can occur during the months of storage.
- solid or tablet products comprising several phases, for example a solid phase and a liquid phase, or a solid phase and a gel phase that is adhered to the phase solid, or even two solid phases.
- washing laundry it may also be desirable to have a solid product which will produce two separate effects, seq uenced or simultaneously simultaneously, but for example on different media. It would be interesting to have a product that can both clean the laundry during the wash cycle and capture dyes that may dye on the treated laundry. In the case where a washing-drying machine is used, it would be interesting to have a product capable both of cleaning the laundry during the washing cycle and able to remain in the drum of the machine at the time of drying of the machine. linen, for example to have a softening or antistatic action on the laundry drying.
- the present invention aims to remedy the above problems by providing a tablet usable in an aqueous medium, easy to manufacture and therefore industrializable, to overcome the presence of disintegration aid agents, and also allowing, if necessary to make combinations of constituents traditionally known to be difficult to combine, for example effective active agents when they are in liquid form.
- the present invention also provides a tablet which on the one hand comprises two solid phases allowing separate and / or sequenced actions, and on the other hand is perfectly cohesive and has excellent hardness.
- the present invention relates to a tablet intended to disintegrate at least partially in an aqueous medium in order to release at least one active agent, comprising at least a first solid phase comprising at least one pulverulent mixture in compacted form, said powder mixture comprising at least least said active agent, and at least one second solid phase, characterized in that said second solid phase comprises at least one textile in compacted form.
- the present invention relates in particular to a tablet intended to disintegrate at least partially in an aqueous medium in order to release at least one active agent, comprising at least a first solid phase comprising at least one pulverulent mixture in compacted form, said powder mixture comprising at least said active agent, and at least a second solid phase, characterized in that said second solid phase comprises at least one textile in compacted form, said textile in compacted form being able to swell with said aqueous medium in contact with the latter .
- the tablet according to the invention is in the form of a single product, comprising at least two cohesive solid phases resulting from the simultaneous compaction on the one hand of a starting powder mixture and on the other hand of a starting textile: thus, the first solid phase comprises at least one pulverulent mixture in compacted form, said powder mixture comprising at least said active agent, and the second solid phase comprises at least one textile in compacted form.
- the starting powder mixture is obtained by mixing ingredients in the form of powders, including the active agent (s), and optionally ingredients in liquid form, conventionally in the manufacture of solid compositions capable of disintegrating in an aqueous medium.
- the starting textile may be in the form of a textile already in compressed form, but having not yet undergone simultaneous compaction with a powder mixture.
- textile in compressed form will refer to a textile having already undergone a compression step, but only, ie independently of the step of simultaneous compaction with the starting powder mixture to obtain the tablet according to the invention.
- textile in compacted form will refer to a textile having undergone the step of compacting simultaneously with the starting powder mixture to obtain the tablet according to the invention.
- the term "textile in compacted form” means the textile in its final configuration, that is to say in the blast, when the textile express compressed form "designate the same textile, but in its configuration before compacting, as a starting product of the manufacture of the tablet according to the invention.
- the tablet according to the invention can be any solid product intended to be placed in contact with an aqueous medium in order to modify the composition of this the latter by means of its active agent (s), for example in order to use this modified aqueous medium as a cleanser, or in order to purify this aqueous medium in order to make it consumable, for example.
- the active agent can be chosen according to the desired action for the tablet.
- it can be selected from detergent agents, surfactants, bleaching agents, etc., for a cleaning action of the tablet, such as washing surfaces such as floors, walls, etc. , or washing clothes, or dishes.
- It may be chosen from disinfecting agents, antimicrobial agents and / or antibacterial agents for a pool water treatment action, or for purifying and / or purifying natural water from a well or a pond.
- tablette includes the terms tablet, lozenge, roller, etc.
- This tablet may have flat and convex upper and lower faces, concave or convex.
- This tablet can be indifferently general shape round, oval, square, rectangular, octagonal, polygonal.
- the tablet according to the invention although comprising two solid phases, one of which comprises or consists of one or more textiles in compacted form, retains a hardness conducive to good cohesion.
- the characteristics of cohesion and hardness are very sensitive parameters and difficult to preserve as soon as a new ingredient is introduced into a solid product formulation.
- the presence of the compacted form of the textile in the tablet according to the invention makes it possible to obtain a solid product with good cohesion and hardness equivalent to, or even greater than, conventional solid products which are generally free of any textile.
- the presence of a compacted form of textile in the tablet according to the invention does not weaken the cohesion of the latter and does not affect its ability to be pelletized.
- the tablet according to the invention although comprising a textile in compacted form, retains excellent cohesion and mechanical strength properties: thus, it can be handled, for example by machines during its packaging, or by consumers, at the time of use, without being damaged and while maintaining its integrity.
- the tablet according to the invention has a high hardness, even increased because of the presence of the textile or compacted form within the second solid phase of the tablet.
- the compacted form of the tablet according to the invention do not destabilize pelletizing and provides interesting hardness characteristics.
- the second solid phase of the tablet according to the invention may comprise several textiles in compacted form.
- the nature and the composition of the tablet according to the invention make it possible to overcome the presence in said tablet of bursting and / or effervescent agents.
- the compacted form of the textile by unfolding in contact with the aqueous medium in which the tablet is placed in contact or dive, acts as a disassembly aid for the tablet.
- the textile may swell with an aqueous medium, for example water, and its volume will increase: in particular, the compacted form of the textile will unfold to try to find its original form, generally substantially two-dimensional.
- This deployment of the textile will promote the separation of grains and / or powder ingredients of the first solid phase of the tablet according to the invention, and thus the disintegration of the latter.
- the first solid phase of the tablet according to the invention comprises a pulverulent mixture in compacted form, the powder mixture comprising at least one active agent intended to modify the composition of the aqueous medium in order to carry out the desired treatment.
- the active agent of the first solid phase of the tablet according to the invention may vary depending on the application envisaged for the tablet.
- this active agent is chosen from detergent agents, disinfecting agents, bleaching agents, bleaching catalysts, oxidizing agents, sequestering agents, fertilizing agents, pesticides, coagulating agents, flocculating agents, agents of cosmetic, nutritional or nutraceutical interest, chemical or biotechnological catalysts, dyes, and mixtures thereof.
- Detergent agents that may be mentioned include cationic surfactants, anionic surfactants, nonionic surfactants, zwitterionic surfactants and mixtures thereof.
- any chlorine derivative known to release active chlorine such as, for example, the sodium salt of N-chloro-4-methylbenzene sulphonamide in anhydrous form or dihydrate, the salt 1,3-dichloro-s-triazine-2,4,6-trione sodium salt in anhydrous form or dihydrate, and mixtures thereof.
- Bleaching agents that may be mentioned include sodium perborate mono and tetra hydrate, sodium carbonate peroxyhydrate, magnesium mono Southernsophalate xH 2 O, potassium monopersulfate, trichloroisocyanuric acid, sodium or potassium salts of hydrated dichloroisocyanurates or anhydrous, and mixtures thereof.
- sodium percarbonate an oxygen bleach
- TAED tetraacetylethylenediamine
- Sequestering agents that may be mentioned include salts and esters of phosphoric acid such as sodium tripolyphosphate, but also ethylene diamine tetraacetic acid (EDTA), sodium citrate, zeolites, nitrilotriacetic acid (NTA), tetrasodium salt of N, N-diacetic acid-L-glutamic acid (GLDA), methylglycine diacetic acid (MGDA), and mixtures thereof.
- salts and esters of phosphoric acid such as sodium tripolyphosphate, but also ethylene diamine tetraacetic acid (EDTA), sodium citrate, zeolites, nitrilotriacetic acid (NTA), tetrasodium salt of N, N-diacetic acid-L-glutamic acid (GLDA), methylglycine diacetic acid (MGDA), and mixtures thereof.
- EDTA ethylene diamine tetraacetic acid
- NDA nitrilotriacetic acid
- fertilizing agents mention may especially be made of phosphoric acid or oligomers of sodium phosphate, and mixtures thereof.
- divalent and trivalent cation salts in particular the aluminum and iron salts of oxidation state III, and mixtures thereof.
- acrylamide polymers such as "FLOPAM AM934" marketed by the company SNF.
- hydrophilic derivatives of vitamin E, vitamin C, retinol, hydroxystylbene derivatives and more specifically resveratrol, carotenoids, lycopene, isoflavonoids and more specifically isoflavones of soybeans probiotics in general and most particularly lactobacilli belonging to the family of lactobacillus casei and paracasei, bifidobacteria, pseudomonadaceae, antagonists of substance P and more specifically lanthanide salts, derivatives of dihydroxyethanolamine (DHEA), and their mixtures.
- DHEA dihydroxyethanolamine
- cereal preparations such as durum wheat sprouts, ground coffee, its lyophilized extracts in native or decaffeinated form, tea, soy isoflavones, and mixtures thereof.
- dyes include indigo, indigo-carmine, tartrazine, and mixtures thereof.
- the powdery mixture of the first solid phase may further comprise any other ingredient that can act as a carrier for the active agent at the first solid phase, and / or any ingredient useful for the intended application.
- the first solid phase can further comprise fillers, alkaline materials, enzymes, optical brighteners, bursting agents and any additive that can be used in tablets, such as for example one or more additives chosen from perfumes, dyes, lubricants, diluents, binders, defoamers, pelletizing aid agents, and mixtures thereof.
- the first solid phase may include bleaches or detergents for application as a laundry or dishwashing composition.
- the first solid phase may comprise fertilizing agents for application as a fertilizer.
- the first solid phase may include pesticides for crop protection.
- the first solid phase may comprise a chlorine releasing agent for tablet application for water disinfection.
- the tablet is used for washing laundry.
- the active agent may for example comprise one or more of the following compounds, alone or in combination, the proportions being given as a percentage by weight of the compound, relative to the total weight of the powder mixture:
- an oxygen bleaching agent pair and its catalyst for example consisting, on the one hand, of 5 to 25%, preferably 10 to 20%, of sodium percarbonate, and on the other hand from 0 to 10%, preferably from 1 to 5% of tetraacetylethylenediamine (TAED),
- TAED tetraacetylethylenediamine
- alkaline materials may be chosen from sodium carbonate, sodium bicarbonate and sodium silicate, and mixtures thereof,
- the enzymes may be chosen from amylase, protease, lipase, mananase, cellulase and mixtures thereof,
- optical brighteners from 0 to 5%, preferably from 0 to 2% optical brighteners.
- the powder mixture may further comprise from 0 to 20%, preferably from 10 to 15%, by weight, of bursting agents, based on the total weight of the powder mixture.
- the powder mixture may also comprise from 0 to 50%, preferably from 2 to 25%, by weight, of fillers, relative to the total weight of the powder mixture.
- Dyestuffs, perfume or pelletizing aid additives may be added in a range of 0 to 5%, preferably 0 to 2%, by weight, based on the total weight of the powder mixture.
- the powder mixture may also comprise ingredients in liquid form, such as surfactants, perfumes, essential hides, however in a limited amount so as not to generate the production disadvantages mentioned above.
- the second compacted solid phase of the tablet according to the invention comprises at least one textile in compacted form.
- the term "textile” means any arrangement of yarns, fibers, filaments, obtained by knitting, weaving or non-woven fabric such as paper.
- such an arrangement has the form of a flexible plate, provided with pores: for example, these pores are the spaces left between the threads, fibers and / or filaments constituting said arrangement, such as, for example, the stitches in the case of knitting.
- This flexible and porous plate is generally two-dimensional, that is to say it has a thickness well below its length and width. This two-dimensional flexible plate is generally easily deformable, particularly foldable on itself.
- the textile of the tablet according to the invention is selected from knits, woven fabrics, nonwovens, and combinations thereof.
- the term "textile in compacted form” means a textile which has undergone a step of simultaneous compaction with the powder mixture described above in order to obtain the tablet according to the invention. invention.
- the starting textile before said compacting step, may be a text already in compression.
- the expression "in compressed form" for the starting textile of the present application is understood to mean a textile, for example of initially two-dimensional initial shape, which has been folded as far as possible on the fabric itself in order to to give it a three-dimensional shape, with a thickness, a length and a width having respective values of the same order, and to which a compressive force has been applied such that the resulting compressed form is substantially free of pores and is in the form of a stable cohesive solid product in a medium such as ambient air (about 20 ° C) and in the absence of any external stress exerted against it.
- the compressed-form textile has the shape of a solid pellet of generally cylindrical shape, with a diameter ranging from 10 to 40 mm, for example 20 mm, and a height ranging from 5 to 20 mm, for example 10 mm.
- the weight of the pellet may for example vary from 1 to 5 g, for example may be 2.6 g.
- the textile of the tablet according to the invention preferably has a generally two-dimensional shape, such as a round, a rectangle, a square, or an oval.
- the textile has in the unfolded form the shape of a rectangle whose width is from 5 to 30 cm, for example is about 22 cm, and the length is from 5 to 30 cm, for example is about 25 cm.
- the dimensions of the textile in the unfolded state can be adapted according to the desired size for the final tablet.
- the density of the textile in compressed form is much higher than the density of the same textile in its initial configuration in uncompressed form, or in other words in the unfolded state, in the absence of stress exerted on this textile.
- Textiles in compressed form that can be used for manufacturing the second solid phase of the tablet according to the invention for example, a density ranging from 0.1 g / cm 3 to 2.5 g / cm 3 , preferably ranging from 0.7 to 1.2 g / cm 3 .
- the textile in compressed form that can be used for manufacturing the second solid phase of the tablet according to the invention can be chosen from textiles already existing under such a compressed form, as for example described in WO2010 / 025576.
- the compacted textile of the tablet according to the invention has, for example, a density ranging from 0.5 g / cm 3 to 5 g / cm 3 , preferably ranging from 0.5 g / cm 3 to 2.5 g / cm 3 .
- the textile of the tablet according to the invention has an absorbency ranging from 0.5 to 35%, preferably from 5 to 20%, by weight.
- the absorbency of a textile means the weight of liquid, for example water, absorbed by said textile, based on the weight of the absorbent textile used.
- the compacted form of the tablet textile according to the invention is intended to unfold in contact with the aqueous medium in which the tablet will be dipped: thus, when the textile in compacted form will come into contact with the aqueous medium, it will swell with aqueous medium, its volume will increase and it will unfold. While unfolding, it will contribute to the disintegration of the tablet.
- the textile of the tablet according to the invention comprises yarns, fibers and / or filaments of a material chosen from cellulose, cotton, polyester, nylon, linen, bamboo and their mixtures.
- the textile is in the form of an amalgam of cellulose fibers, such as paper.
- the yarns, fibers and filaments of the abovementioned materials have an absorbing power enabling the textile of the tablet according to the invention to act as a disintegration aid for the tablet when the latter is brought into contact with an aqueous medium.
- said material is cotton.
- the cotton has an absorbency of about 8.5% by weight: in other words, cotton fibers can absorb up to 8.5% of their weight in water.
- said material is linen. Flax has an absorbency of 12% by weight.
- said material is a cellulose, preferably a natural and biodegradable cellulose.
- biodegradable is meant within the meaning of the present application, a material able to decompose and disappear in a natural environment in a predetermined time, for example in less than six months.
- the textile consists solely of biodegradable material.
- the textile in the unfolded state once the tablet is dissolved in the aqueous medium, for example to discard.
- the textile when the textile is made of biodegradable material, it can be left in the natural environment until decomposition.
- the compacted form of the textile comprises at least one active compound in dry form.
- the compacted form of the tablet of the invention may contribute to the disintegration of the latter, but it can also participate in the desired action or actions for the tablet according to the application considered.
- the active compound in dry form may be chosen from the active agents mentioned above for the powdery mixture of the first solid phase.
- the active compound in dry form is more particularly chosen from active ingredients that are useful for applying the tablet as a cleaning product for the laundry to be used in a washing machine or a washing-drying machine.
- the active compound is chosen from surfactants, perfumes, anti-color transfer agents, softening agents, anti-static agents, deodorizing agents, bactericidal agents, fungicidal agents, disinfectants, and mixtures thereof.
- the active compounds may be incorporated into the textile intended to be used for the preparation of tablets according to the invention in liquid form before any compression and / or compaction of said textile, in other words in the initial unfolded state of the textile. So, before any compression, in other words in the unfolded state, the textile is impregnated with a solution of the desired active compound or compounds, and then the textile thus impregnated is compressed, as described in application WO2010 / 025576.
- the amount of solution used to impregnate the textile depends on the absorbency of the selected textile: generally, this amount ranges from 5 to 150 ml for a textile having dimensions such as those described above.
- the liquid phase of the active compounds is removed and the textile in compressed form obtained comprises the active compound (s) in dry form.
- the step of simultaneous compaction with the starting powder mixture of such a textile already in compressed form does not modify the dry state of the active compound (s) impregnating the textile .
- surfactants that can be used as active compounds for the textile of the tablet according to the invention, mention may be made of cationic surfactants, anionic surfactants, nonionic surfactants, zwitterionic surfactants, and mixtures thereof. .
- the anti-color transfer agents make it possible to absorb the dyestuffs of the detergent bath and to avoid their redeposition on the linen.
- anti-neck transfer agents which can be used as active compounds for the textile of the tablet according to the invention, mention may be made of N-substituted-hydroxy-haloalkyl quaternary ammonium salts such as 2-hydroxy-3 -chloropropyltrimethylammonium, salts of ammonium epoxy propyl such as epoxy propyl trimethylammonium chloride, quaternary ammonium compounds, polyamphotieri, quaternized starch derivatives, proteins, chitin, chitosan, chloride choline, polyvinyl amines, polyethylene imines, and mixtures thereof.
- N-substituted-hydroxy-haloalkyl quaternary ammonium salts such as 2-hydroxy-3 -chloropropyltrimethylammonium
- salts of ammonium epoxy propyl such as epoxy propyl trimethylammonium chloride
- quaternary ammonium compounds polyamphotieri, quaternized starch derivatives, proteins, chitin
- the softening agents make it possible to give the linen flexibility and to avoid it being rough.
- softening agents that can be used as active compounds for the textile of the tablet according to the invention, mention may be made of quaternary ammonium salts of cationic, anionic or amphoteric type, and mixtures thereof.
- Anti-static agents help to reduce and eliminate the accumulation of static electricity on laundry, especially during the drying phase.
- anti-static agents that can be used as active compounds for the textile of the tablet according to the invention, mention may be made of amine-based surfactants and amides with long aliphatic chains (sometimes ethoxylated), quaternary ammonium salts such as chloride cocamidopropyl betaine betahentrimoniu, phosphoric acid esters, polyethylene glycol esters, polyols and mixtures thereof.
- deodorizing agents that can be used as active compounds for the textile of the tablet according to the invention, mention may be made of cyclodextrin, sodium bicarbonate or a complex mixture of essential oils capable of neutralizing odors (tobacco, perspiration, animals, ). These active molecules can be encapsulated to maintain maximum efficiency for a specified time.
- the textile of the tablet according to the invention thus allows a prolonged presence of these molecules in the washing machine (several consecutive washings).
- Bactericidal, fungicidal and / or disinfectant agents help eliminate germs, fungi and bacteria when washing clothes.
- bactericidal, fungicidal and / or disinfectant agents that can be used as active compounds for the textile of the tablet according to the invention, mention may be made of sodium hypochlorite, hydrogen peroxide, ethanol or isopropanol, and mixtures thereof. .
- the active compound is a color antitransferant.
- the textile of the tablet according to the invention when the textile of the tablet according to the invention is in its unfolded state in the washing bath, it retains the dyes of the detergent bath and prevents their redeposition on the laundry.
- the active compound is a softening agent.
- laundry washing cycles in general comprise a first phase, washing itself and during which a detergent is used, followed by a second phase, rinsing, during from which the detergent is removed.
- the first phase generally has a duration ranging from 5 minutes to about 60 minutes, for example 10 minutes depending on the machines and programs used.
- the tablet disintegrates in general during the first 5 to 15 minutes of the cycle: the consequence is for example that the softening agent when it is present in these tablets, is released at the beginning of cycle. It can thus happen that the softening agent is prematurely and unnecessarily consumed at the time of washing. Furthermore, in a washer-dryer machine, the softening agent was removed with the drain water after rinsing. It can not therefore produce a softening effect on the laundry during the drying phase.
- One solution would be to open the machine after emptying, to introduce into the drum before drying a softening active, for example in the form of a dedicated softening tablet.
- this tablet having both a laundry action with a detergent asset present in the first phase solid tablet, and a softening action, thanks to a softening active compound present on the textile in compacted form, for example in encapsulated form for prolonged and / or delayed action.
- the tablet according to the invention thus makes it possible to eliminate a binding operation for the operator of the washing machine.
- the textile of the tablet according to the invention because of its nature and shape , is not discharged with the drain water after the rinsing step.
- the textile, with its softening agent remains in the drum of the washing machine.
- the textile of the tablet according to the invention releases its softening agent during the drying step of the machine.
- the active compound is a surfactant.
- a surfactant for example, it is possible to integrate in the tablet according to the invention. large amounts of compounds known to be active in liquid form. For example, it is thus possible to incorporate large amounts of surfactants initially in liquid form, or even perfumes or essential oils initially in liquid form.
- These active compounds are present in the dry state in the textile form. compacted, but they recover their liquid state when the textile absorbs the aqueous medium and returns to its unfolded state.
- said second solid phase comprises a plurality of textiles in compacted form.
- the second solid phase phase may consist of one or more textiles in compacted form.
- the content of the textile (s) in compacted form ranges from 2 to 20%, by weight, relative to the total weight of the tablet.
- the one or more textiles in compacted form can be distributed within said first solid phase.
- At least a portion of the second solid phase for example a portion of the textile in compacted form, is visible on at least one surface of said tablet.
- said visible portion of the compacted textile can come into contact with the aqueous medium as soon as the tablet is immersed in this aqueous medium.
- the compacted form of the textile can thus help disintegrate the tablet quickly.
- a first part of the second solid phase for example a first part of the textile in compacted form, is visible on the surface of a first face of the tablet
- a second part of the second solid phase for example a second part of the textile in compacted form or a second textile in compacted form, being visible on the surface of a second face of the tablet, opposite to said first face.
- the tablet may have the shape of a fairly flat cylinder of diameter D and height H, said second solid phase consisting of a compacted form of textile in the form of a pellet of height H and diameter d less than D, said pad being located in the center of the tablet: thus, the first solid phase forms a ring around said pad, the latter flush on the two opposite faces of the tablet.
- the first solid phase comprises a plurality of layers of different compositions.
- a first textile in compacted form is housed within a first layer of said first solid phase
- a second textile in compacted form being housed within a second layer of said first solid phase.
- the present invention also relates to a method for preparing a tablet as described above comprising the following steps:
- the compressive force is from 10 to 80 kN, for example from 20 to 50 kN, for a mass of starting powder mixture ranging from 10 to 60 g, for example 40 g, and for a textile under compressed form having for example the shape of a solid pellet of generally cylindrical shape, with a diameter ranging from 10 to 40 mm, for example 20 mm and a height ranging from 5 to 20 mm, for example 10 mm.
- the weight of the textile pellet in compressed form may, for example, vary from 1 to 5 g, for example maybe 2.6 g. It is thus possible to obtain a tablet in the form of a disk with a diameter ranging from 20 to 60 mm, for example 45 mm, and a height of 3 to 30 mm.
- the compressed form textile has a density ranging from 0.1 g / cm 3 to 2.5 g / cm 3 , preferably from 0.7 to 1.2 g / cm 3
- step c) said powder mixture is placed at the bottom of the matrix of the pelletizer in the form of a bed of powders, and then said textile is placed in compressed form on led it it of powders. After compacting, a tablet is obtained in which at least a portion of the second solid phase is visible on one side of the tablet.
- at least a portion of the compacted form textile is flush with the surface of a face of the tablet and may be directly in contact with the aqueous medium in which the tablet will be dipped during use.
- step c) a portion of said powder mixture is placed at the bottom of the matrix of the pelletizer in the form of a bed of powders, said textile is placed in compressed form on said bed of powders, then the remainder of said mixture is added powder on the said textile in compressed form. After compacting, a tablet is obtained in which all of the second solid phase is trapped in the first solid phase of the tablet.
- the first solid phase of the tablet comprises several layers
- a powder mixture is prepared separately for each desired layer.
- Each layer is then compacted in the pelletizer by applying a compressive force.
- the different layers can be made with or without precompression depending on the powders used as starting raw materials and depending on the desired compaction rate for these layers.
- a low precompression for example a force ranging from 0 to 30 kN, preferably from 5 to 20 kN, will be applied, with a holding time ranging from 0 to 30 seconds, in order to obtain uniform layers and a final tablet with no lack of adhesion between the different layers of the component.
- a compressed form textile may be introduced in one or more layers, in the same manner as previously described for the preparation of a monolayer tablet.
- the first solid phase of the tablet according to the invention may comprise several layers, one or more of these layers comprising at least a portion of the second solid phase in the form of a textile in compacted form.
- the first solid phase of the tablet according to the invention being constituted by three layers, two outer layers and an intermediate layer, a textile in compacted form is present in each of the outer layers, the intermediate layer being free of textile.
- the compacted form of textile of each outer layer is flush with the surface of the outer face of said layer.
- Tablets according to the invention have excellent hardness.
- the presence of a compacted form of textile does not destabilize pelletizing and does not affect the cohesion of the tablet obtained.
- - Figures 1 A-1 C are respectively views from above, from below and from the side of a first variant of the tablet according to the invention
- - Figures 2A-2C are respectively views from above, from below and from the side of a second variant of the tablet according to the invention
- -Figu res 3A-3C are respectively top, bottom and side views of a third variant of the tablet according to the invention.
- the powder mixture P of the following composition, indicated in Table I below, is prepared and suitable for an application of laundry detergent to the washing machine (the amounts are given as a percentage by weight, based on the total weight of the composition):
- the textile does not include any active compound.
- the pelletizer used is a press comprising a matrix and punches of "round diameter 45 mm" shape.
- the textile already in compressed form above is deposited in the matrix of the pelletizer in the central position. Then 40 g of the powder mixture P above is added to the matrix above the textile in compressed form. The upper punch of the pelletizer is then placed and the pelletizing cycle is started with a set point of 50 kN. During this step, the powder mixture P is compacted to form the first solid phase of the tablet. During this pelletizing step, the textile in compressed form is also compacted to form the second solid phase of the tablet: in this second solid phase, the textile is in compacted form.
- the compacted form of the textile has a density of
- the compacted form of the textile has a density multiplied by 26 relative to the density of the fabric in unfolded state prior to compression / compaction. Moreover, the textile in compacted form has a density almost multiplied by 1.5 (greater than about 56%) relative to the density of the textile in compressed form.
- the content of the textile in compacted form by weight, relative to the total weight of the tablet is: 6%.
- a biss according to the invention is obtained in the form of a fairly flat cylinder with a height of 1.9 cm.
- Such a tablet 1 is represented in FIGS. 1A-1C: the tablet 1 comprises a first solid phase 2 corresponding to the pulverulent mixture above in compacted form and a second solid phase in the form of the textile in compacted form 3.
- the first solid phase 2 is disposed around the textile in compacted form 3: however, a part 3a of the second solid phase, in other words the compacted form of textile 3, is visible on a surface 5 of the tablet 1, corresponding to the surface which was located opposite from the bottom of the pelletizer die.
- the tablet thus obtained has excellent hardness. It also has a very good cohesion, despite the presence of the compact form of textile 3.
- the compacted form of textile 3 comes into contact with this aqueous medium by its visible part 3a and swells with this aqueous medium. He then tends to return to its unfolded state and helps disintegrate the tablet.
- the compacted form of textile may comprise an active compound, which is released into the aqueous medium, will then act on this aqueous medium depending on the desired application.
- the compacted form of the textile has a density of
- the compacted form of the textile has a density multiplied by 20 relative to the density of the textile in the unfolded state prior to compression / compaction.
- the textile form The compacted mass has a mass density almost multiplied by 1.2 (about 20% higher) than the density of the textile in compressed form.
- the content of the textile in compacted form by weight, relative to the total weight of the tablet is: 6%.
- a tablet according to the invention is obtained in the form of a fairly flat cylinder of height 2.1 cm.
- Such a tablet 1 1 is shown in Figures 2A-2C: the tablet 1 1 comprises a first solid phase 12 corresponding to the pulverulent mixture above in compacted form and a second solid phase in the form of the compacted form of textile 13.
- the first solid phase 12 is disposed around the textile in compacted form 1 3 so that it completely traps and no part of said textile is visible outside.
- the tablet thus obtained has excellent hardness. It also has a very good cohesion, despite the presence of a compacted form of textile 13.
- the compacted form of the textile may comprise an active compound, which is then released into the aqueous medium, and will then act on this aqueous medium depending on the desired application.
- a tablet is produced according to the invention, comprising a first solid phase comprising three layers and a second solid phase comprising two textiles in compacted form as follows: A T1 textile already in compressed form as above is deposited in the matrix the pelletizer in a central position. Then 15 g of the powder mixture P1 above is added to the matrix above the textile in compressed form. The upper punch of the pelletizer is then placed and a pelletizing cycle is started with a setpoint of 9 kN.
- the upper punch is removed. This gives a first layer on which 10 g of P1 powder mixture is poured in order to form a bed of powders.
- the upper punch of the pelletizer is then placed on this bed of powders and a new pelletizing cycle is started with a set point of 9 kN.
- the upper punch is removed.
- a second layer is thus obtained on which 1 g of pulverulent mixture P2 is spread in order to form a bed of powders.
- a second textile T2 in compressed form as described above is deposited on this bed of powders.
- the upper punch of the pelletizer is then placed and a last pelletizing cycle is started with a set point of 50 kN.
- a tablet according to the invention is obtained in the form of a fairly flat cylinder of height 2.0 cm.
- Each textile in compacted form has a density of 1.2 g / cm 3 .
- each textile in compacted form has a density multiplied by 24 relative to the density of the textile in the unfolded state before compression / compacting.
- the compacted form of the textile has a density that is almost multiplied by 1.4 (about 44% higher) relative to the density of the textile in compressed form.
- the textile content in compacted form (including the two textiles T1 and T2) by weight, relative to the total weight of the tablet is: 1 1.
- the tablet 21 comprises a first solid phase 22 comprising three layers: a first outer layer 24 of composition P1 powder mixture, a second outer layer 25 of composition powder mixture P2, and an intermediate layer 26 of composition P1 powder mixture.
- the tablet 21 comprises a second solid phase 23 comprising two textiles in compacted form, the first textile T1 in compacted form 27 housed in the first outer layer 24, and the second textile T2 in compacted form 28 housed in the second outer layer 25.
- the first outer layer 24 traps the first textile in compacted form 27 leaving a portion 27a of said textile visible on the outer surface of this layer.
- the second outer layer 25 traps the second textile in compacted form 28 leaving a portion 28a thereof. second textile visible on the outer surface of this second layer.
- the intermediate layer 26 is textile-free.
- the tablet thus obtained has excellent hardness. It also has a very good cohesion, despite the presence of two textiles in compacted form.
- Textiles T1 and T2 in compacted form may comprise active compounds, for example different, which are released in the aqueous medium, will each act on this aqueous medium depending on the desired applications.
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Mechanical Engineering (AREA)
- Textile Engineering (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261708131P | 2012-10-01 | 2012-10-01 | |
FR1259261A FR2996235B1 (fr) | 2012-10-01 | 2012-10-01 | Tablette comprenant un textile compacte |
PCT/FR2013/052318 WO2014053755A1 (fr) | 2012-10-01 | 2013-09-30 | Tablette comprenant un textile compacté |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2904086A1 true EP2904086A1 (de) | 2015-08-12 |
EP2904086B1 EP2904086B1 (de) | 2017-01-11 |
Family
ID=47295031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13785505.2A Active EP2904086B1 (de) | 2012-10-01 | 2013-09-30 | Tablette mit einem verdichteten stoff |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2904086B1 (de) |
FR (1) | FR2996235B1 (de) |
WO (1) | WO2014053755A1 (de) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH699454A1 (de) | 2008-09-05 | 2010-03-15 | Markus Werth | Leicht entfaltbares und parfümiertes Tüchlein. |
WO2011131585A1 (en) * | 2010-04-20 | 2011-10-27 | Henkel Ag & Co. Kgaa | Laundry article having cleaning properties |
-
2012
- 2012-10-01 FR FR1259261A patent/FR2996235B1/fr active Active
-
2013
- 2013-09-30 EP EP13785505.2A patent/EP2904086B1/de active Active
- 2013-09-30 WO PCT/FR2013/052318 patent/WO2014053755A1/fr active Application Filing
Non-Patent Citations (1)
Title |
---|
See references of WO2014053755A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2904086B1 (de) | 2017-01-11 |
FR2996235B1 (fr) | 2014-10-31 |
WO2014053755A1 (fr) | 2014-04-10 |
FR2996235A1 (fr) | 2014-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102414999B1 (ko) | 기능성 과립을 포함하는 세탁용 시트 | |
EP1479755B1 (de) | Waschmittelzusammensetzung zum Gebrauch in einer Textilwasch- oder Geschirrspülmaschine | |
EP1299517B2 (de) | Maschinengeschirrspülmittel mit zusatznutzen | |
FR2985274A1 (fr) | Structures fibreuses comprenant des particules et leur procede de fabrication | |
FR3092338A1 (fr) | Sachets comprenant des matériaux de paroi en film perforés et ses procédés de fabrication | |
KR101910298B1 (ko) | 세척 활성 물질이 온도 의존적 활성화되는 강력한 세탁용 세제 시트 | |
CA2701741A1 (fr) | Procede de compaction d'une composition pulverulente a volume constant | |
DE10003429A1 (de) | Wasch- oder Reinigungsmittelportion mit kontrollierter Wirkstofffreisetzung | |
EP2904086B1 (de) | Tablette mit einem verdichteten stoff | |
EP3383989B1 (de) | Beschichtete waschmitteltablette | |
FR3037258A1 (fr) | Composition absorbante d'humidite comprenant un agent sequestrant | |
WO1983004417A1 (fr) | Preparation detergente | |
FR3099372A1 (fr) | Tablette solide chlorée désinfectante de taille réduite | |
FR2880623A1 (fr) | Composition solide, divisee, stable, comprenant du phmbg et un liberateur d'oxygene pour le traitement de l'eau | |
DE20022229U1 (de) | Maschinengeschirrspülmittel mit Zusatznutzen | |
WO2024003065A1 (fr) | Composition de nettoyage solide comprenant au moins une cavité | |
FR2926088A1 (fr) | Tablette detergente multicouche | |
KR101783949B1 (ko) | 고형물 주방 세제 및 그 제조 방법 | |
FR3109392A1 (fr) | Ensemble de tablette détergente | |
FR2969171A1 (fr) | Tablette adoucissante pour textile | |
FR2927770A1 (fr) | Procede de compaction d'une composition pulverulente a volume constant. | |
FR2684968A1 (fr) | Systemes de conteneurisation pour compositions pour l'agriculture. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150421 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20160304 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BERGER, JACQUES Inventor name: BROSSE, JACQUES Inventor name: FRANCOIS, CELINE |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTC | Intention to grant announced (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20160729 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 861288 Country of ref document: AT Kind code of ref document: T Effective date: 20170115 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013016524 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20170111 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 861288 Country of ref document: AT Kind code of ref document: T Effective date: 20170111 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170411 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170412 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170511 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170411 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170511 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013016524 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
26N | No opposition filed |
Effective date: 20171012 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20170930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170930 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170930 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170930 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20130930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170111 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20220923 Year of fee payment: 10 Ref country code: DE Payment date: 20220916 Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602013016524 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20230930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240403 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240812 Year of fee payment: 12 |